yes and no. the person who covers adxs from zack is grant zeng. i find him to be credible, ranked top 30 in performance out of over 3500 analysts. go read his comparison article yourself and judge to see if it is substance or fluff; google: grant zeng advaxis aduro.
on the other hand,, there are indeed some reports from zacks as if they are computer generated...with zero insight
good man,,,for someone who does not mind to show her colonoscopy in the morning show,,,if katie knows about what patterson did,,i am pretty sure she will check it out,,,,,girl power
nothing personnal---hasn't Zack,s been de-bunked ---i don't know how many investors wave the zacks flag when pumping their favorite
I bet we smoke past all PTs and hopefully break a few records in the process....
LOL, Check out ( China Ming Yang symbol MY) wind turbine and solar maufacturer ER due 04/07 there should be a nice surprise coming in earnings, Normally I don't reccommend stocks, But this is worth the look, OK no more hehe
Sentiment: Strong Buy
You sound like an English teacher...stop being a pompous #$%$. Message boards are about sharing thoughts....its what one says that matters, not how it is said or in what format....grow up.
cat,,make it happen,,,make it into a 4 part series with the final one on adxs only hehe
Carl June was on our medical advisory board. That series will look pretty short sighted if they don't include Yvonne Patterson as well. The GOG is involved with the companies phase three in our cervical cancer study. The lot of them will look pretty rediculous if CAR-T is less then stellar in the solid tumor space. Yvonnes science is truly intelligent and awe inspiring!
chinaman, I believe the show will give more positive sentiment on the whole Immuno sector, and you are right about the Car-T I saw the preview trailers, and Dr Klausner from Juno was a guess speaker, Dr Rosenberg from NCI was in the preview, I will be looking forward to watching the 3 part series, we might pick up new technologies in the background, Equipment Etc. HeHe GLTA
Sentiment: Strong Buy
1. doc when first came on,,,loaned adxs money and to be paid back in adxs shares.
2. doc along with the management team has been taking salary in adxs shares (varying percentage, but on each paycheck)
3. mauro moved from merck as their immuno chief to come to adxs after "pressure testing" adxs vac for 6 mons at merck.
4. adage would stick its neck out 2 times putting money into a co that underwent reverse split, ex-ceo with sec past, and history of using a pr firm that turned rogue. also,,,gross negligence in publishing a graph with a wrong Y axis unit so that those who interpret the data literally would think it is possible for a 3 inch mouse to grow a 20 inch cervical cancer. i still have nightmare over that.
all the above point to one explanation. hmmm
because her producers more likely than not will go after the obvious,,,,the cart players. it is also very likely the tv folks are not sophisticated enough to realize the short comings of the current cart approach AND the more important question: what else is out there and what is coming up next (as justice has written repeatedly on this topic). they should interview justice to get a comprehensive, sensible overview!
perhaps we can contact katie c directly and update her about adxs, like some did by sending info to AF directly.
but, if i am wrong and adxs is indeed included in the show,,,then, um,,loop up! hehe
Advaxis, Inc. (NASDAQ:ADXS) has received a Outperform rating, according to the latest rank of 1 from research firm, Zacks. The counter could manage an average rating of 1 from 4 analysts. 4 market experts have complete faith in the companys business and have marked it as a strong buy.
Advaxis, Inc. (NASDAQ:ADXS) shares are expected to touch $14.3 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 2.39. The target price could hit $18 on the higher end and $12 on the lower end.
Company has also disclosed other Insider Buying and Selling activities to the Exchange Commission ., Berman Richard J, Director of Advaxis Inc, unloaded 14,530 shares at an average price of $2.63 on May 9, 2014. The total amount of the transaction was worth $38,214, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Shares of Advaxis, Inc. (NASDAQ:ADXS) witnessed hefty buying and the price closed up 14.53% at $8.59. There was no let up in intensity from the bulls and the price headed north amid a strong volume of 1,643,709 shares. The opening commenced on a calm note with the first trade at $7.53 but the buying pressure soon took the shares to an intraday high of $8.66. However, the traders and investors booked some profits at the higher levels. Advaxis, Inc. (NASDAQ:ADXS) has a 52-week high of $13.74 and a 52-week low of $2.46. The company has a market cap of $203 million.
Sentiment: Strong Buy
Hope you're right gajj_4. I think we'll all be celebrating, but the funny thing is even bigger and better things lie ahead after that!